Oculis touts Phase 2 re­sults in dry eye dis­ease, but most da­ta aren't sta­tis­ti­cal­ly sig­nif­i­cant

Oculis teased that its dry eye dis­ease ther­a­py worked in a mid-stage tri­al, but it stopped short of re­port­ing sta­tis­ti­cal­ly sig­nif­i­cant da­ta across most end­points …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER